| Dr Betty Siu, MD | |
|
3510 Old Washington Rd, Suite #100, Waldorf, MD 20602-3233 | |
| (301) 609-5200 | |
| (301) 609-5220 |
| Full Name | Dr Betty Siu |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 3510 Old Washington Rd, Waldorf, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073609038 | NPI | - | NPPES |
| D0062287 | Other | MD | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0062287 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cook And Siu Pc | 6406997550 | 2 |
News Archive
A new study addressing this issue has been published in Viruses that shows that functional neutralizing antibody tests are more relevant indicators than the presence or absence of binding antibodies.
On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio - more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.
An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 9 days ago
| Entity Name | Civista Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992701825 PECOS PAC ID: 7618864976 Enrollment ID: O20040302000207 |
News Archive
A new study addressing this issue has been published in Viruses that shows that functional neutralizing antibody tests are more relevant indicators than the presence or absence of binding antibodies.
On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio - more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.
An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 9 days ago
| Entity Name | Cook & Siu Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780852129 PECOS PAC ID: 6406997550 Enrollment ID: O20100112000021 |
News Archive
A new study addressing this issue has been published in Viruses that shows that functional neutralizing antibody tests are more relevant indicators than the presence or absence of binding antibodies.
On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio - more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.
An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 9 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140522000040 |
News Archive
A new study addressing this issue has been published in Viruses that shows that functional neutralizing antibody tests are more relevant indicators than the presence or absence of binding antibodies.
On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio - more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.
An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 9 days ago
| Entity Name | Privia Care Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164874426 PECOS PAC ID: 3274801139 Enrollment ID: O20170619000055 |
News Archive
A new study addressing this issue has been published in Viruses that shows that functional neutralizing antibody tests are more relevant indicators than the presence or absence of binding antibodies.
On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio - more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.
An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Betty Siu, MD 3510 Old Washington Rd, Suite #100, Waldorf, MD 20602-3233 Ph: (301) 609-5200 | Dr Betty Siu, MD 3510 Old Washington Rd, Suite #100, Waldorf, MD 20602-3233 Ph: (301) 609-5200 |
News Archive
A new study addressing this issue has been published in Viruses that shows that functional neutralizing antibody tests are more relevant indicators than the presence or absence of binding antibodies.
On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio - more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.
An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 9 days ago
Dr. Sailaja Nandipati, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Old Washington Rd, Suite 202, Waldorf, MD 20602 Phone: 301-843-2223 Fax: 301-843-2355 | |
Dr. Zafar Abulhasan Ansari, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Post Office Rd Ste E, Waldorf, MD 20602 Phone: 301-396-4800 | |
Firas Al Sammarrai, M.B.CH.B. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Saint Patricks Dr, Waldorf, MD 20603 Phone: 301-373-7900 Fax: 301-373-6900 | |
Dr. Alex Ryzhikov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Saint Patricks Dr, Waldorf, MD 20603 Phone: 301-705-7870 Fax: 301-705-7628 | |
Dr. Lorenzo Childress Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Crain Hwy, Waldorf, MD 20601 Phone: 240-427-1926 Fax: 240-427-1927 | |
Seetaramayya Nagula, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12070 Old Line Ctr, Suite 200, Waldorf, MD 20602 Phone: 301-645-8035 Fax: 301-645-5229 |